Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

The study found that Short Anagen Syndrome results in short hair growth not due to hair fragility, and hair may grow longer after puberty.

Low ferritin and high Anti TPO levels are linked to early hair greying.

PRP treatment helps 70.1% of hair loss patients after two sessions.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Spotted lunula may help identify alopecia areata.

Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.

Dermoscopy can help diagnose secondary syphilis by distinguishing it from other skin issues.

Alitretinoin may help treat mild to moderate alopecia areata.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Topical and oral minoxidil are the best treatments for monilethrix.

Scalp biopsies are essential for diagnosing congenital alopecia areata.

Trichorrhexis nodosa is common hair breakage, often due to styling, and new treatments are being explored.

Removing ingrown hairs can significantly improve persistent kerion in children.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Younger children with alopecia areata often experience more severe hair loss and longer illness, with allergies and nutrient deficiencies playing a role.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.